Skip to content

Clinical trials

Lung Diseases, Interstitial trials in Italy with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Status: Unknown status Country / region: Italy Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20131
20141
20181
20191
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Gabriela Riemekasten1
IRCCS Azienda Ospedaliero-Universitaria di Bologna1
IRCCS Policlinico S. Donato1
Medical University of Silesia1
Professor Adrian Covic1
University Hospital Tuebingen1
University of Parma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial8
COVID-193
Autoimmune Diseases1
Coronavirus Infections1
Dyspnea1
Emergencies1
Inflammation1
Influenza, Human1
Pneumonia, Mycoplasma1
Pneumonia, Ventilator-Associated1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.